ENTRY       D11753                      Drug
NAME        Evinacumab (USAN/INN);
            Evinacumab (genetical recombination) (JAN);
            Evinacumab-dgnb;
            Evkeeza (TN)
PRODUCT     EVKEEZA (Regeneron Pharmaceuticals)
FORMULA     C6480H9992N1716O2042S46
EXACT_MASS  145991.7936
MOL_WEIGHT  146081.9345
SEQUENCE    (Heavy chain)
            EVQLVESGGG VIQPGGSLRL SCAASGFTFD DYAMNWVRQG PGKGLEWVSA ISGDGGSTYY
            ADSVKGRFTI SRDNSKNSLY LQMNSLRAED TAFFYCAKDL RNTIFGVVIP DAFDIWGQGT
            MVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
            QFNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
            QEEMTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK
            SRWQEGNVFS CSVMHEALHN HYTQKSLSLS LGK
            (Light chain)
            DIQMTQSPST LSASVGDRVT ITCRASQSIR SWLAWYQQKP GKAPKLLIYK ASSLESGVPS
            RFSGSGSGTE FTLTISSLQP DDFATYYCQQ YNSYSYTFGQ GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H140-L214, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'140-L'214, H'153-H'209, H'267-H'327, H'373-H'431, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
REMARK      ATC code: C10AX17
            Product: D11753<US>
EFFICACY    Antihyperlipidemic, Anti-angiopietin like 3
  DISEASE   Homozygous familial hypercholesterolemia [DS:H00155]
  TYPE      Monoclonal antibody
COMMENT     Treatment of dyslipidemia
TARGET      ANGPTL3 [HSA:27329] [KO:K22288]
  PATHWAY   hsa04979(27329)  Cholesterol metabolism
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX17 Evinacumab
                  D11753  Evinacumab (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, Other
               Evinacumab
                D11753  Evinacumab (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                ANGPTL3
                 D11753  Evinacumab (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11753
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11753
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11753
DBLINKS     CAS: 1446419-85-7
            PubChem: 405226619
///
